Chek the Channels
Meet 125 Mgmt Teams
NobleCon16 Panelists to Discuss if a Cure for Type 1 Diabetes is Imminent
(Note: companies that could be impacted by the content of this article are listed at the base of the story [desktop version]. This article uses third-party references to provide a bullish, bearish, and balanced point of view; sources are listed after the Balanced section.)
Is the day when we have a functional cure for Type 1 Diabetes approaching? There are 1.25 million people in the U.S. alone afflicted with T1D. Noble Capital Markets has assembled a panel from among the world’s top medical researchers in this field to discuss advancements and therapies toward curing Type 1. The panel discussion will take place at NobleCon16 being held from February 16 – 18 at the Hard Rock Guitar Hotel in Fort Lauderdale.
A medical cure, not a new or improved treatment, for T1D, will be the primary discussion. Advancements toward this goal began to accelerate after an unplanned meeting by two of this year’s panelists a couple of years ago during NobleCon14. It was during that NobleCon conference that an idea came together that is now leading to promising clinical study results. The panel will also include a famous advocate and T1D sufferer who is elevating the voice of those with diabetes through his national podcast. The panel discussion is titled: Type 1 Diabetes: A Functional Cure Could Be Imminent.
The panelists are:
Dr. Matthias von Herrah, MD, Founder of the Type 1 Diabetes Center at La Jolla Institute for Immunology
Dr. Bastiano Sanna, President, and COO of Semma Therapeutics
Dr. Steven Perrin, CEO, and co-Founder of Anelixis Therapeutics.
Eric Paslay, Platinum-selling songwriter/performer, Owner of Apple Podcast Level With Me
The organizers of this year’s NobleCon have again assembled exciting company presentations and addresses that are of interest to anyone seeking to discover still small companies that could make a big difference with what is now going on inside their doors.
NobleCon conferences experience 70% repeat attendance by investors who want to build on their understanding of opportunities and perhaps meet privately with company management to best understand their company’s potential. Money managers, family office finance professionals, investment advisors, independent brokers, and equity analysts go to NobleCon each year to learn of companies, products, and breakthroughs that could easily be overlooked in a world where larger well-known companies get the majority of the spotlight. Some of tomorrow's household names are companies that benefit from more light being shed on them today. That’s what NobleCon and ChannelChek are about -- Shedding more light on small and micro-cap opportunities in order to unearth actionable ideas.
Pictured: Eric Paslay with his wife Natalie Harker, November 2017